BYSI
BeyondSpring Inc.
There isn't enough reported data to score BYSI yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
BYSI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
BYSI's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
BYSI PE Valuation
BYSI has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
BYSI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect BYSI's losses to shrink, with revenue declining.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
BYSI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.16 | -$0.02 |
| Q1 2026 | -$0.24 | -$0.11 |
| Q4 2025 | -$0.08 | +$0.26 |
| Q3 2025 | -$0.07 | +$0.34 |
| Q2 2025 | -$0.14 | +$0.27 |
| Q1 2025 | -$0.13 | +$0.34 |
| Q4 2024 | -$0.34 | +$0.20 |
| Q3 2024 | -$0.41 | +$0.21 |
BYSI is still losing money, but far less than before: $0.16 per share over the past year, against $2.04 at its worst in late 2020.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over BYSI on earnings quality, reporting a profit while its opponent remains loss making.
BYSI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2024 | $500K | +14% |
| Q1 2024 | $500K | +14% |
| Q4 2023 | $438K | +30% |
| Q3 2023 | $438K | +30% |
| Q2 2023 | $437.5K | +29% |
| Q1 2023 | $437.5K | +29% |
| Q4 2022 | $337.5K | -0.1% |
| Q3 2022 | $337.5K | +0.1% |
BYSI's revenue has slid since its 2024 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2024 | -742% | +799 points |
| Q1 2024 | -742% | +799 points |
| Q4 2023 | -1099% | +1335 points |
| Q3 2023 | -1099% | +1335 points |
| Q2 2023 | -1541% | +1537 points |
| Q1 2023 | -1541% | +1537 points |
| Q4 2022 | -2434% | +670 points |
| Q3 2022 | -2434% | +3011 points |
BYSI's operating margin was −742% last quarter, up 799 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over BYSI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
BYSI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.8M | +$2.1M |
| Q1 2026 | -$3.3M | +$971K |
| Q4 2025 | -$5.5M | -$5.5M |
| Q3 2025 | -$4.2M | -$4.2M |
| Q2 2025 | -$5.9M | -$5.9M |
| Q1 2025 | -$4.2M | -$4.2M |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
BYSI has burned cash in six of the last eight quarters: −$17M over the past year, against −$10M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over BYSI on cash generation, producing positive trailing cash flow while its opponent burns cash.
BYSI Net Leverage
BYSI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
BYSI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.3 | Neutral |
| Stochastic | 21.8 | Neutral |
BYSI's weekly RSI is 36 (neutral) and its Stochastic is 22 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
BYSI PE vs Healthcare Sector
BYSI has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
BYSI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.63 | 4.8% below |
| 20 week MA | $0.86 | 30% below |
| 50 week MA | $1.33 | 55% below |
| 100 week MA | $1.58 | 62% below |
| 200 week MA | $1.61 | 63% below |
BYSI is in a downtrend: it's below all five of its weekly moving averages, and 63% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over BYSI on trend strength, trading above more of its moving averages.
BYSI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.9 | $11.1 | -30% |
| 2021 | $11.1 | $4.92 | -55% |
| 2022 | $4.92 | $1.69 | -66% |
| 2023 | $1.69 | $0.90 | -47% |
| 2024 | $0.90 | $1.62 | +80% |
| 2025 | $1.62 | $1.84 | +14% |
| 2026 YTD | $1.84 | $0.60 | -67% |
BYSI has finished lower in four of the last six years. It's down 67% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over BYSI on returns for 2026, with the stronger performance.